Therapure Biopharma

What Therapure Biopharma does

Therapure Biopharma Inc. is a privately held Canadian biopharmaceutical company founded in 2008 and headquartered in Mississauga, Ontario. The company operates as an integrated contract development and manufacturing organization (CDMO) serving pharmaceutical and biotechnology companies globally, with 251-500 employees organized across three operating divisions: Therapure Biomanufacturing (the core CDMO business), Therapure Innovations (drug discovery and R&D), and Evolve Biologics (plasma-derived therapeutics).

Therapure Biomanufacturing delivers integrated biologics CDMO services from process development through commercial manufacturing, leveraging a state-of-the-art cGMP compliant facility. The division targets small and mid-size pharmaceutical companies and biotechnology firms requiring outsourced biologics production, viral vector manufacturing, plasmid gene therapies, and scalable cGMP manufacturing capabilities. Therapure Innovations develops innovative protein therapeutics targeting liver cancer, anemia, and hepatitis C using proprietary platform technologies. Evolve Biologics advances a patented plasma protein extraction technology positioned as the first major advancement in plasma protein extraction in over 75 years, enabling plasma-derived therapeutics at higher purity, efficiency, and reliability than market alternatives.

The company generates revenue through long-term contract manufacturing agreements with enterprise pharma and biotech clients, operating a managed services revenue model with project-specific, quote-based pricing. Its go-to-market approach is direct enterprise sales targeting companies lacking in-house biologics manufacturing infrastructure. The company maintains a content-driven marketing presence through its website blog and social media channels to support thought leadership in biologics and biomanufacturing. No disclosed financial metrics, funding rounds, or named customer relationships are available in the input data.

Name

Therapure Biopharma

Legal name

Therapure Biopharma Inc.

Website

https://therapurebio.com

Company type

Private

Founded year

2008

Operating status

Operating

Headcount range

251–500 employees

Short description

Therapure Biopharma is a Canadian integrated biologics CDMO with cGMP manufacturing facilities serving pharmaceutical and biotechnology companies globally. It operates three divisions: Therapure Biomanufacturing (CDMO services), Therapure Innovations (protein therapeutics R&D), and Evolve Biologics (patented plasma protein extraction technology).

Ownership category

akta.pro rank

Product category

Biologics Contract Manufacturing Services (CDMO)

NAICS

Biological Product (except Diagnostic) Manufacturing (325414), Pharmaceutical Preparation Manufacturing (325412), Research and Development in Biotechnology (except Nanobiotechnology) (541714)

SIC

Pharmaceutical Preparations (2834), Biological Products, (No Disgnostic Substances) (2836), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Biologics (mAbs/Recombinant Proteins) CDMO (HLAGABAC)

akta.pro secondary industries

Drug Substance–Drug Product Integrated CDMO (HLAGABAG), Clinical Trial Material (CTM) Manufacturing & Supply CDMO (HLAGABAK)

Keywords

• Biologics contract manufacturing
• CGMP manufacturing services
• Plasma protein extraction
• Protein therapeutics development
• Biopharmaceutical CDMO

Headquarters

HQ city

Mississauga

HQ country

Canada

HQ region

North America

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain

Revenue model

1. CDMO Manufacturing Services: Contract development and manufacturing organization providing integrated biologics CDMO services. Revenue is generated through long-term manufacturing contracts with pharmaceutical and biotechnology companies for biologics production using cGMP facilities.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

Therapure Biopharma is an integrated Contract Development and Manufacturing Organization (CDMO) that provides biologics development and manufacturing services through its Therapure Biomanufacturing division, operating a flexible state-of-the-art cGMP facility. The company also conducts proprietary drug discovery and R&D for protein therapeutics targeting liver cancer, anemia, and hepatitis C via Therapure Innovations, and advances patented plasma protein extraction technology for plasma-derived therapeutics via Evolve Biologics.

Product overview

Therapure Biopharma is a biotechnology company organized into two main divisions: Therapure Biomanufacturing (a global CDMO providing integrated biologics manufacturing services with cGMP facilities) and Evolve Biologics (a division focused on developing protein therapeutics for liver cancer, anemia, and hepatitis C using proprietary platform technologies, with a patented breakthrough in plasma protein extraction).

Differentiator

Problem solved

Functional benefit

Brands

• Therapure Biomanufacturing: Global contract development and manufacturing organization (CDMO) providing integrated biologics CDMO services with scientific and manufacturing expertise and flexible state-of-the-art cGMP facility
• Therapure Innovations
• Evolve Biologics

Products and services

• Therapure Biomanufacturing Global CDMO providing integrated biologics contract development and manufacturing services, with scientific and manufacturing expertise backed by a flexible state-of-the-art cGMP facility for clients needing biologics production at scale.
• Therapure Innovations Drug discovery and R&D division developing innovative protein therapeutics in liver cancer, anemia, and hepatitis C using proprietary platform technologies.
• Evolve Biologics Division advancing a patented plasma protein extraction technology designed to deliver plasma-derived therapeutics at higher levels of purity, efficiency, and reliability than currently available in the market.

Quantifiable outcome

• First major advancement in plasma protein extraction for over 75 years

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Scale indicators1 record

Recent moves5 records

Expansion highlights4 records

Direct peers

• KBI Biopharma: Mid-scale biologics CDMO offering process development, analytical services, and cGMP manufacturing. Closely comparable to Therapure in scale, scope, and target client segment.
• Lonza Group: Global leader in biologics CDMO services including mammalian cell culture and recombinant protein manufacturing. Directly comparable to Therapure Biomanufacturing's integrated biologics CDMO offering.
• WuXi Biologics: Global biologics CDMO offering discovery, development, and manufacturing services. Closely comparable to Therapure's integrated biologics platform and target biotech/pharma client base.
• Aldevron (Danaher): CDMO specializing in biologics inputs including plasmid DNA, mRNA, and proteins. Comparable to Therapure's biologics manufacturing focus and biotech customer base.
• Samsung Biologics: Large-scale biologics CDMO providing end-to-end contract manufacturing from cell line development to commercial supply. Comparable as a direct competitor for outsourced biologics manufacturing contracts.

Broad incumbents

• Grifols: Global leader in plasma-derived therapeutics. Most directly comparable to Therapure's Evolve Biologics plasma protein extraction vertical, though at vastly larger scale.
• Brammer Bio (Thermo Fisher): Viral vector and gene therapy CDMO integrated into Thermo Fisher. Comparable to Therapure's exposure to viral vector and gene therapy manufacturing referenced in its biotech customer segment.
• Catalent (Novo Holdings): Large diversified CDMO with biologics capabilities alongside broader fill-finish and softgel services. Overlaps with Therapure's drug-product and biologics CDMO work.
• Patheon / Thermo Fisher Scientific (CDMO): Pharma services division of Thermo Fisher offering contract development and manufacturing including biologics. Competes with Therapure for outsourced pharma manufacturing deals at a much larger scale.

Regional players

• BioVectra: Canadian CDMO with biologics and small-molecule manufacturing capabilities based in Atlantic Canada. Most relevant geographic peer to Therapure's Mississauga, Canada footprint.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/412591

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Subsidiaries3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Therapure Biopharma